Table 2.
Primary studies included in the evaluated reviews.
Primary study | Study design | Follow-up in months | Outcome variables | Review including the primary study | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Authors | Miron et al. [17] |
Miron et al. [18] | Castro et al. [19] | Panda et al. [20] | Zhou et al. [21] | Moraschini and Barboza [24] |
Najeeb et al. [22] | Tavelli et al. [23] | |||
Agarwal et al. [28] | Case control | 6 | Root coverage CAF versus CAF + AM versus CAF + PRF |
X | |||||||
Agarwal et al. [29] | RCT | 12 | Intrabody defect regeneration OFD + DFDBA versus OFD + DFDBA + PRF |
X | X | X | X | X | X | ||
Agarwal et al. [30] | RCT | 12 | Intrabody defect regeneration OFD + DFDBA versus OFD + DFDBA + PRP |
X | X | ||||||
Ajwani et al. [31] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + PRF-L |
X | X | X | X | X | |||
Aleksić et al. [32] | RCT | 12 | Root coverage CAF + CTG versus CAF + PRF |
X | |||||||
Aroca et al. [33] | RCT | 6 | Root coverage CAF versus CAF + PRF |
X | X | X | |||||
Atchuta et al. [34] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + ALLBG + PRF |
X | |||||||
Aydemir Turkal et al. [35] |
RCT | 6 | Intrabody defect regeneration OFD + EMD versus OFD + PRF + EDM |
X | |||||||
Bahammam and Attia [36] | RCT | 6 | Intrabody defect regeneration OFD + PRF versus OFD + SBG + PRF |
X | |||||||
Bajaj et al. [37] | RCT | 9 | Furcation degree II OFD versus OFD + PRF-L versus OFD + PRP |
X | |||||||
Bansal and Bharti [38] | RCT | 6 | Intrabody defect regeneration OFD + DFDBA versus OFD + DFDBA + PRF |
X | X | X | X | X | |||
Bodhare et al. [39] | RCT | 6 | Intrabody defect regeneration OFD + bioguide versus OFD + bioguide +PRF |
X | X | ||||||
Camargo et al. [40] | RCT | 9 | Intrabody defect regeneration OFD + BPBM versus OFD + PRP + BPBM |
X | |||||||
Chadwick et al. [41] | RCT | 6 | Intrabody defect regeneration OFD + DFDBA versus OFD + PRF |
X | X | ||||||
Chandradas et al. [42] | RCT | 9 | Intrabody defect regeneration OFD + PRF versus OFD + XBG + PRF |
X | |||||||
Chatterjee et al. [43] | RCT | 9 | Intrabody defect regeneration OFD + PRF versus OFD + TPRF (activated in titanium tubes) |
X | |||||||
Demir et al. [44] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRP + SBG |
X | |||||||
Dogan et al. [45] | RCT | 6 | Root coverage CAF versus CAF + PRF |
X | |||||||
Döri et al. [46] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + PRF + HA |
X | X | ||||||
Elbehwashy et al. [47] | RCT | 6 | Intrabody defect regeneration OFD + PRF + ascorbic acid versus OFD + PRF |
X | |||||||
Elgendy and Abo Shady [48] |
RCT | 6 | Intrabody defect regeneration OFD + HA nano bone® versus OFD + PRF-L + nano bone® |
X | X | X | X | X | |||
Eren and Atilla [49] | RCT | 6 | Root coverage CAF + CTG versus CAF + PRF |
X | X | X | |||||
Galav et al. [50] | RCT | 9 | Intrabody defect regeneration OFD + BAG versus OFD + PRF |
X | X | ||||||
Gamal et al. [51] | Case control | 9 | Intrabody defect regeneration OFD + XB versus OFD + PRGF versus OFD + PRF |
X | X | ||||||
Goyal et al. [52] | RCT | 12 | Intrabody defect regeneration ABBM + GTR + PRP versus ABBM + GTR |
X | |||||||
Gupta et al. [53] | RCT | 6 | Intrabody defect regeneration OFD + EMD versus OFD + PRF |
X | X | X | X | ||||
Gupta et al. [54] | RCT | 6 | Root coverage CAF versus CAF + PRF |
X | X | ||||||
Hanna et al. [55] | RCT | 12 | Intrabody defect regeneration OFD + HA + sasline versus OFD + PRP + HA |
X | X | ||||||
Harnack et al. [56] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + PRP |
X | |||||||
Hassan et al. [57] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + ABG + PRP |
X | |||||||
Hazari et al. [58] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + SBG + PRF |
X | |||||||
Ilgenli et al. [59] | RCT | 6 | Intrabody defect regeneration OFD + PRP versus OFD + ABG + PRP |
X | |||||||
Jalaluddin et al. [60] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + PRP |
X | |||||||
Jalaluddin et al. [61] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + PRP |
X | |||||||
Jankovic et al. [62] | RCT | 9 | Root coverage CAF + EMD versus CAF + PRF |
X | X | X | |||||
Jankovic et al. [63] | RCT | 6 | Root coverage CAF + CTG versus CAF + PRF |
X | X | X | |||||
Kang et al. [64] | Case control | 6 | Intrabody defect regeneration O FD versus OFD + PRP versus OFD + PRF |
X | |||||||
Kanoriya et al. [65] |
RCT | 9 | Intrabody defect regeneration OFD + PRF versus OFD + PRF + Alendronato 1% |
X | X | ||||||
Kaushick et al. [66] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + SBG + PRP |
X | |||||||
Keceli et al. [67] | RCT | 6 | Root coverage CAF + CTG versus CAF + CGT + PRF |
X | X | ||||||
Kukreja et al. [68] | RCT | 6 | Intrabody defect regeneration OFD + DFDBA versus OFD + DFDBA + PRP |
X | X | ||||||
Lekovic et al. [69] | RCT | 6 | Intrabody defect regeneration OFD + PRF-L versus OFD + PRF-L + BMPM |
X | X | X | X | ||||
Markou et al. [70] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + PRP + ABG |
X | |||||||
Martande et al. [71] |
RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRF versus OFD + PRF + Atorvastatina 1.2% |
X | X | ||||||
Mathur et al. [72] | RCT | 6 | Intrabody defect regeneration OFD + ABG versus OFD + PRF |
X | X | X | X | ||||
Menezes et al. [73] | RCT | 12 | Intrabody defect regeneration OFD + DFDBA + PRP versus OFD + DFDBA |
X | |||||||
Naqvi et al. [74] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + BAG versus OFD + PRF + BAG |
X | X | ||||||
Okuda et al. [75] | Case control | 12 | Intrabody defect regeneration OFD versus OFD + PRP + SBG |
X | |||||||
Ozdemir and Okte [76] | RCT | 6 | Intrabody defect regeneration OFD + ABBM versus OFD + PRP + ABBM |
X | X | ||||||
Padma et al. [77] | RCT | 6 | Root coverage CAF versus CAF + PRF |
X | X | X | |||||
Panda et al. [78] | RCT | 9 | Intrabody defect regeneration OFD + barrier membrane versus OFD + barrier membrane + PRF |
X | |||||||
Paolantonio et al. [79] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + PRF-L + ABG |
X | |||||||
Patel et al. [80] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + PRF |
X | |||||||
Pavani et al. [81] | RCT | 6 | Intrabody defect regeneration OFD versus OFD + PRF + SBG |
X | |||||||
Pham [82] | RCT | 12 | Intrabody defect regeneration OFD + PRF versus GRT versus OFD |
X | |||||||
Pradeep et al. [83] | Case control | 9 | Effects on intrabody regeneration OFD versus OFD + PRP |
X | X | ||||||
Pradeep et al. [84] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRP versus OFD + PRF-L |
X | X | X | X | X | X | ||
Pradeep et al. [85] | RCT | 9 | Intrabody defect regeneration OFD + 1% MF versus OFD + PRF versus OFD + 1% MF + PRF |
X | X | X | X | X | |||
Pradeep et al. [86] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRF + SBG |
X | |||||||
Pradeep et al. [87] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRF versus OFD + PRF + Rosuvastatina 1.2% |
X | X | ||||||
Rajaram et al. [88] | RCT | 24 | Root coverage DLSBF versus DLSBF + PRF |
X | |||||||
Rosamma et al. [89] | RCT | 12 | Intrabody defect regeneration OFD versus OFD + PRF-L |
X | X | ||||||
Sezgin et al. [90] | RCT | 6 | Intrabody defect regeneration OFD versus ABBM + PRP versus OFD + ABBM |
X | X | ||||||
Shah et al. [91] | RCT | 6 | Intrabody defect regeneration OFD + DFDBA versus OFD + PRF-L |
X | X | X | X | X | |||
Sharma and Pradeep [92] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRF |
X | X | X | X | ||||
Sharma and Pradeep [93] |
RCT | 9 | Furcation degree II OFD + PRF versus OFD + PRF-L |
X | X | X | X | ||||
Shukla et al. [94] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + SBG + PRP |
X | |||||||
Thamaraiselvan et al. [95] | Case control | 6 | Root coverage CAF versus CAF + PRF |
X | X | X | |||||
Thorat et al. [96] | RCT | 9 | Intrabody defect regeneration OFD versus OFD + PRF |
X | X | X | X | X | X | ||
Tunalɩ et al. [97] | RCT | 12 | Root coverage CAF + CTG versus CAF + PRF |
X | X | X | |||||
Yajamanya et al. [98] |
RCT | 9 | Intrabody defect regeneration OFD + BAG versus OFD + PRF |
X | X | ||||||
Yilmaz et al. [99] | RCT | 12 | Intrabody defect regeneration GTR + BM + PRP versus BM + GTR |
X |
CAF, coronary displacement flap; EMD, Emdogain; CTG, connective tissue graft; DLSBF, double lateral sliding bridge flap; AM, amniotic membrane; OFD, surgical therapy; DFDBA, demineralized bone matrix; PRP, platelet-rich plasma; L-PRF, leucocyte-and platelet-rich fibrin; MF, metformin; HA, hydroxyapatite; BM, barrier membrane; ABG, autogenous bone graft; BAG, bioactive glass; ABBM, bovine anorganic graft; BMPM, bone morphogenic protein; SBG, synthetic bone graft; PRGF, platelet-derived growth factor; XB, bovine xenograft; BM, bone mineral; ALLBG, allogenic bone graft; RCT, randomized clinical trial.